| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |